Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Hungary Bill notified to include cannabinoids on narcotics list ...
  • Panama Bill regulating hemp approved in first debate ...
  • Germany First cannabis club in Lower Saxony harvests 200 plants ...
  • Belgium List of notified herbal products for smoking updated ...
  • Lithuania Seimas approves amendments to Fibre Hemp Law ...
  • Uruguay More potent cannabis variant sold in pharmacies from today ...
  • Italy EC assessing compliance of bill restricting hemp to industrial uses ...
  • Europe Council adopts new CLP regulation ...
  • France No plans proposed to extend medical cannabis experiment ...
  • California - United States Court rejects industry attempt to block new hemp regulation ...
  • Germany Majority of survey respondents think cannabis legalisation was wrong ...
  • World International E-waste Day raises awareness of e-waste ...
View all
News analysis

Mainstream US drugstore chains announce plans to sell CBD

Written by CannIntelligence | 29th March 2019

CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states...

FDA sets the date for hearing on legalising hemp-derived CBD

Written by CannIntelligence | 1st March 2019

The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according...

Deal signals plans for ‘sustainable’ bio-synthesised CBD

Written by CannIntelligence | 26th February 2019

The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for...

Global CBD rules will get tougher, then normalise, expert predicts

Written by CannIntelligence | 20th February 2019

Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a...

'More women than men' have tried CBD in UK

Written by Freddie Dawson | 19th February 2019

More women than men have tried CBD products, according to a new report from CBD-Intel. Among other findings in the report is that health-conscious men are more likely than others to try CBD ...

Singapore ministries declare cannabis mad, bad and dangerous

Written by Freddie Dawson | 18th February 2019

Singaporean authorities do not believe there is sufficient evidence supporting the efficacy of “raw” cannabis, considering the plant and its derivatives to be a dangerous drug with few medical benefits ...

WHO recommends removing CBD from world narcotics schedules

Written by Barnaby Page | 18th February 2019

CBD is likely to be removed from the scope of the most significant international treaty on drug control, following a favourable report by the World Health Organization (WHO), which also recommends downgrading cannabis ...

Cannabis companies team up with pharma firm to supply Europe

Written by CannIntelligence | 14th February 2019

Two of the largest legal cannabis companies, Wayland and International Cannabis Corp, are teaming up with a multinational pharmaceutical organisation in a bid to create significant amounts of CBD for the European market ...

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.